Barclays initiates Darling Ingredients stock at Equalweight, $58 target

Barclays initiated Darling Ingredients at Equalweight with a $58 price target, below the broader Wall Street range of $70 to $85, while TD Cowen reiterated Buy with a $76 target. Q1 2026 EPS came in at $0.83 versus $0.59 expected, though revenue was slightly light at $1.55 billion versus $1.56 billion consensus. The company also secured a U.S. patent for Nextida GC and is set to host its 2026 Investor Day on May 11.

Analysis

DAR’s move is increasingly a policy-plus-execution story, but the market is likely over-assigning near-term certainty to the policy leg. The first-order winner is the DGD/JV cash flow stream, yet the second-order effect is that higher expected biofuel margins can attract incremental supply and political scrutiny, making the equity more sensitive to headline risk than the underlying spread would suggest.

The bigger setup is that the stock’s rerating from renewable diesel optionality may be reaching diminishing returns, while the next leg higher depends on businesses the market usually values at a lower multiple than policy-linked cash flows. That creates a valuation trap: if collagen/health-wellness growth is good but not exceptional, the market may keep assigning a ‘good asset, mediocre rest-of-business’ discount even with strong earnings beats.

The key risk window is the next 1-3 months, not the next 1-3 years. Any adverse ruling on RIN reallocation or softening policy expectations could compress sentiment fast because a meaningful part of the 2026-2027 upside is already being capitalized now; conversely, if management uses Investor Day to prove a credible path to self-funded growth and debt reduction, the multiple can hold despite policy noise.

The contrarian angle: consensus may be underestimating how much of DAR’s current price reflects an implied call option on clean-fuels policy rather than on operating execution. If the policy backdrop stays favorable, upside may still be capped unless management can show that the non-DGD businesses are worth more than a sum-of-the-parts discount; if policy disappoints, the downside is faster because the market has likely crowded into the same ‘renewables beneficiary’ trade.

Key Decisions for Investors

• Hold a tactical long DAR into Investor Day only via call spreads, not outright equity: buy 2-4 month calls and finance with higher strike sales to express upside from execution while limiting damage if policy headlines turn negative.
• If already long DAR, trim 25-40% ahead of any RIN/SRE headline risk over the next 2-6 weeks; the stock looks more vulnerable to a policy air pocket than to gradual fundamental erosion.
• Relative value: long VLO / short DAR for the next 1-3 months if you want exposure to the same renewable fuel complex but with less single-name dependence on a successful valuation re-rating.
• For longer-duration investors, use pullbacks to build a staggered long in DAR only if management provides a credible bridge from debt reduction to capital returns by early 2027; absent that, the equity remains a policy-sensitive compounder with limited margin of safety.